Exicure Inc. (XCUR)
NASDAQ: XCUR
· Real-Time Price · USD
6.70
-0.77 (-10.31%)
At close: Jun 23, 2025, 2:35 PM
-10.31% (1D)
| Bid | 6.71 |
| Market Cap | 42.33M |
| Revenue (ttm) | 500K |
| Net Income (ttm) | -9.7M |
| EPS (ttm) | -4.35 |
| PE Ratio (ttm) | -1.54 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 6.8 |
| Volume | 21,983 |
| Avg. Volume (20D) | 15,408 |
| Open | 6.72 |
| Previous Close | 7.47 |
| Day's Range | 6.59 - 7.43 |
| 52-Week Range | 1.44 - 36.00 |
| Beta | 3.73 |
About XCUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XCUR
Website n/a
5 months ago
-15.07%
Exicure shares are trading higher after the compan...
Unlock content with
Pro Subscription
7 months ago
+35.86%
Exicure shares are trading higher after the company reported a year-over-year increase in Q3 PES results. Additionally, the company announced it entered into a purchase agreement for $1.3 million and $8.7 million in equity financing.
2 months ago · businesswire.com
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML).